 | • レポートコード：QYR2104Z3280 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、鉄欠乏性貧血療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口鉄療法、非経口鉄療法、赤血球輸血、その他）、用途別市場規模（病院、クリニック、在宅ケア、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・鉄欠乏性貧血療法の市場動向 ・企業の競争状況、市場シェア ・鉄欠乏性貧血療法の種類別市場規模（経口鉄療法、非経口鉄療法、赤血球輸血、その他） ・鉄欠乏性貧血療法の用途別市場規模（病院、クリニック、在宅ケア、その他） ・鉄欠乏性貧血療法の北米市場規模2016-2027（アメリカ、カナダ） ・鉄欠乏性貧血療法のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・鉄欠乏性貧血療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・鉄欠乏性貧血療法の中南米市場規模2016-2027（メキシコ、ブラジル） ・鉄欠乏性貧血療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Allergan、AMAG Pharmaceuticals、Integra Lifesciences、Galderma Pharma、Teoxane、Sinclair Pharma、Pieris、Pharmacosmos AS、Johnson & Johnson、Luitpold Pharmaceuticals、Keryx Biopharmaceuticals、Vifor Pharma、Akebia Therapeutics） ・結論 |
Iron deficiency anemia is anemia that occurs when iron stores cannot meet the needs of normal red blood cell production.This is due to insufficient iron intake, reduced absorption, increased demand, and excess iron deficiency or loss.The morphology is small cell hypochromic anemia.Iron deficiency anemia is not a disease, but the symptoms of the disease, symptoms and anemia degree and onset of the delay related.
Market Analysis and Insights: Global Iron Deficiency Anemia Therapy Market
The global Iron Deficiency Anemia Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Iron Deficiency Anemia Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Iron Deficiency Anemia Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Iron Deficiency Anemia Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Iron Deficiency Anemia Therapy market.
Global Iron Deficiency Anemia Therapy Scope and Market Size
Iron Deficiency Anemia Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Iron Deficiency Anemia Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Oral Iron Therapy
Parenteral Iron Therapy
Red Blood Cell Transfusion
Other
Segment by Application
Hospitals
Clinics
Home Healthcare
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Allergan
AMAG Pharmaceuticals
Integra Lifesciences
Galderma Pharma
Teoxane
Sinclair Pharma
Pieris
Pharmacosmos AS
Johnson & Johnson
Galderma Pharma
Teoxane
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Iron Deficiency Anemia Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral Iron Therapy
1.2.3 Parenteral Iron Therapy
1.2.4 Red Blood Cell Transfusion
1.2.5 Other
1.3 Market by Application
1.3.1 Global Iron Deficiency Anemia Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Healthcare
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Iron Deficiency Anemia Therapy Market Perspective (2016-2027)
2.2 Iron Deficiency Anemia Therapy Growth Trends by Regions
2.2.1 Iron Deficiency Anemia Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Iron Deficiency Anemia Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Iron Deficiency Anemia Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Iron Deficiency Anemia Therapy Industry Dynamic
2.3.1 Iron Deficiency Anemia Therapy Market Trends
2.3.2 Iron Deficiency Anemia Therapy Market Drivers
2.3.3 Iron Deficiency Anemia Therapy Market Challenges
2.3.4 Iron Deficiency Anemia Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Iron Deficiency Anemia Therapy Players by Revenue
3.1.1 Global Top Iron Deficiency Anemia Therapy Players by Revenue (2016-2021)
3.1.2 Global Iron Deficiency Anemia Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Iron Deficiency Anemia Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Iron Deficiency Anemia Therapy Revenue
3.4 Global Iron Deficiency Anemia Therapy Market Concentration Ratio
3.4.1 Global Iron Deficiency Anemia Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Iron Deficiency Anemia Therapy Revenue in 2020
3.5 Iron Deficiency Anemia Therapy Key Players Head office and Area Served
3.6 Key Players Iron Deficiency Anemia Therapy Product Solution and Service
3.7 Date of Enter into Iron Deficiency Anemia Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Iron Deficiency Anemia Therapy Breakdown Data by Type
4.1 Global Iron Deficiency Anemia Therapy Historic Market Size by Type (2016-2021)
4.2 Global Iron Deficiency Anemia Therapy Forecasted Market Size by Type (2022-2027)
5 Iron Deficiency Anemia Therapy Breakdown Data by Application
5.1 Global Iron Deficiency Anemia Therapy Historic Market Size by Application (2016-2021)
5.2 Global Iron Deficiency Anemia Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Iron Deficiency Anemia Therapy Market Size (2016-2027)
6.2 North America Iron Deficiency Anemia Therapy Market Size by Type
6.2.1 North America Iron Deficiency Anemia Therapy Market Size by Type (2016-2021)
6.2.2 North America Iron Deficiency Anemia Therapy Market Size by Type (2022-2027)
6.2.3 North America Iron Deficiency Anemia Therapy Market Size by Type (2016-2027)
6.3 North America Iron Deficiency Anemia Therapy Market Size by Application
6.3.1 North America Iron Deficiency Anemia Therapy Market Size by Application (2016-2021)
6.3.2 North America Iron Deficiency Anemia Therapy Market Size by Application (2022-2027)
6.3.3 North America Iron Deficiency Anemia Therapy Market Size by Application (2016-2027)
6.4 North America Iron Deficiency Anemia Therapy Market Size by Country
6.4.1 North America Iron Deficiency Anemia Therapy Market Size by Country (2016-2021)
6.4.2 North America Iron Deficiency Anemia Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Iron Deficiency Anemia Therapy Market Size (2016-2027)
7.2 Europe Iron Deficiency Anemia Therapy Market Size by Type
7.2.1 Europe Iron Deficiency Anemia Therapy Market Size by Type (2016-2021)
7.2.2 Europe Iron Deficiency Anemia Therapy Market Size by Type (2022-2027)
7.2.3 Europe Iron Deficiency Anemia Therapy Market Size by Type (2016-2027)
7.3 Europe Iron Deficiency Anemia Therapy Market Size by Application
7.3.1 Europe Iron Deficiency Anemia Therapy Market Size by Application (2016-2021)
7.3.2 Europe Iron Deficiency Anemia Therapy Market Size by Application (2022-2027)
7.3.3 Europe Iron Deficiency Anemia Therapy Market Size by Application (2016-2027)
7.4 Europe Iron Deficiency Anemia Therapy Market Size by Country
7.4.1 Europe Iron Deficiency Anemia Therapy Market Size by Country (2016-2021)
7.4.2 Europe Iron Deficiency Anemia Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Iron Deficiency Anemia Therapy Market Size (2016-2027)
8.2 Asia-Pacific Iron Deficiency Anemia Therapy Market Size by Type
8.2.1 Asia-Pacific Iron Deficiency Anemia Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Iron Deficiency Anemia Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Iron Deficiency Anemia Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Iron Deficiency Anemia Therapy Market Size by Application
8.3.1 Asia-Pacific Iron Deficiency Anemia Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Iron Deficiency Anemia Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Iron Deficiency Anemia Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Iron Deficiency Anemia Therapy Market Size by Region
8.4.1 Asia-Pacific Iron Deficiency Anemia Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Iron Deficiency Anemia Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Iron Deficiency Anemia Therapy Market Size (2016-2027)
9.2 Latin America Iron Deficiency Anemia Therapy Market Size by Type
9.2.1 Latin America Iron Deficiency Anemia Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Iron Deficiency Anemia Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Iron Deficiency Anemia Therapy Market Size by Type (2016-2027)
9.3 Latin America Iron Deficiency Anemia Therapy Market Size by Application
9.3.1 Latin America Iron Deficiency Anemia Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Iron Deficiency Anemia Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Iron Deficiency Anemia Therapy Market Size by Application (2016-2027)
9.4 Latin America Iron Deficiency Anemia Therapy Market Size by Country
9.4.1 Latin America Iron Deficiency Anemia Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Iron Deficiency Anemia Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Iron Deficiency Anemia Therapy Market Size (2016-2027)
10.2 Middle East & Africa Iron Deficiency Anemia Therapy Market Size by Type
10.2.1 Middle East & Africa Iron Deficiency Anemia Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Iron Deficiency Anemia Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Iron Deficiency Anemia Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Iron Deficiency Anemia Therapy Market Size by Application
10.3.1 Middle East & Africa Iron Deficiency Anemia Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Iron Deficiency Anemia Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Iron Deficiency Anemia Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Iron Deficiency Anemia Therapy Market Size by Country
10.4.1 Middle East & Africa Iron Deficiency Anemia Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Iron Deficiency Anemia Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Iron Deficiency Anemia Therapy Introduction
11.1.4 Allergan Revenue in Iron Deficiency Anemia Therapy Business (2016-2021)
11.1.5 Allergan Recent Development
11.2 AMAG Pharmaceuticals
11.2.1 AMAG Pharmaceuticals Company Details
11.2.2 AMAG Pharmaceuticals Business Overview
11.2.3 AMAG Pharmaceuticals Iron Deficiency Anemia Therapy Introduction
11.2.4 AMAG Pharmaceuticals Revenue in Iron Deficiency Anemia Therapy Business (2016-2021)
11.2.5 AMAG Pharmaceuticals Recent Development
11.3 Integra Lifesciences
11.3.1 Integra Lifesciences Company Details
11.3.2 Integra Lifesciences Business Overview
11.3.3 Integra Lifesciences Iron Deficiency Anemia Therapy Introduction
11.3.4 Integra Lifesciences Revenue in Iron Deficiency Anemia Therapy Business (2016-2021)
11.3.5 Integra Lifesciences Recent Development
11.4 Galderma Pharma
11.4.1 Galderma Pharma Company Details
11.4.2 Galderma Pharma Business Overview
11.4.3 Galderma Pharma Iron Deficiency Anemia Therapy Introduction
11.4.4 Galderma Pharma Revenue in Iron Deficiency Anemia Therapy Business (2016-2021)
11.4.5 Galderma Pharma Recent Development
11.5 Teoxane
11.5.1 Teoxane Company Details
11.5.2 Teoxane Business Overview
11.5.3 Teoxane Iron Deficiency Anemia Therapy Introduction
11.5.4 Teoxane Revenue in Iron Deficiency Anemia Therapy Business (2016-2021)
11.5.5 Teoxane Recent Development
11.6 Sinclair Pharma
11.6.1 Sinclair Pharma Company Details
11.6.2 Sinclair Pharma Business Overview
11.6.3 Sinclair Pharma Iron Deficiency Anemia Therapy Introduction
11.6.4 Sinclair Pharma Revenue in Iron Deficiency Anemia Therapy Business (2016-2021)
11.6.5 Sinclair Pharma Recent Development
11.7 Pieris
11.7.1 Pieris Company Details
11.7.2 Pieris Business Overview
11.7.3 Pieris Iron Deficiency Anemia Therapy Introduction
11.7.4 Pieris Revenue in Iron Deficiency Anemia Therapy Business (2016-2021)
11.7.5 Pieris Recent Development
11.8 Pharmacosmos AS
11.8.1 Pharmacosmos AS Company Details
11.8.2 Pharmacosmos AS Business Overview
11.8.3 Pharmacosmos AS Iron Deficiency Anemia Therapy Introduction
11.8.4 Pharmacosmos AS Revenue in Iron Deficiency Anemia Therapy Business (2016-2021)
11.8.5 Pharmacosmos AS Recent Development
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Details
11.9.2 Johnson & Johnson Business Overview
11.9.3 Johnson & Johnson Iron Deficiency Anemia Therapy Introduction
11.9.4 Johnson & Johnson Revenue in Iron Deficiency Anemia Therapy Business (2016-2021)
11.9.5 Johnson & Johnson Recent Development
11.10 Luitpold Pharmaceuticals
11.10.1 Luitpold Pharmaceuticals Company Details
11.10.2 Luitpold Pharmaceuticals Business Overview
11.10.3 Luitpold Pharmaceuticals Iron Deficiency Anemia Therapy Introduction
11.10.4 Luitpold Pharmaceuticals Revenue in Iron Deficiency Anemia Therapy Business (2016-2021)
11.10.5 Luitpold Pharmaceuticals Recent Development
11.11 Keryx Biopharmaceuticals
11.11.1 Keryx Biopharmaceuticals Company Details
11.11.2 Keryx Biopharmaceuticals Business Overview
11.11.3 Keryx Biopharmaceuticals Iron Deficiency Anemia Therapy Introduction
11.11.4 Keryx Biopharmaceuticals Revenue in Iron Deficiency Anemia Therapy Business (2016-2021)
11.11.5 Keryx Biopharmaceuticals Recent Development
11.12 Vifor Pharma
11.12.1 Vifor Pharma Company Details
11.12.2 Vifor Pharma Business Overview
11.12.3 Vifor Pharma Iron Deficiency Anemia Therapy Introduction
11.12.4 Vifor Pharma Revenue in Iron Deficiency Anemia Therapy Business (2016-2021)
11.12.5 Vifor Pharma Recent Development
11.13 Akebia Therapeutics
11.13.1 Akebia Therapeutics Company Details
11.13.2 Akebia Therapeutics Business Overview
11.13.3 Akebia Therapeutics Iron Deficiency Anemia Therapy Introduction
11.13.4 Akebia Therapeutics Revenue in Iron Deficiency Anemia Therapy Business (2016-2021)
11.13.5 Akebia Therapeutics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Iron Deficiency Anemia Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral Iron Therapy
Table 3. Key Players of Parenteral Iron Therapy
Table 4. Key Players of Red Blood Cell Transfusion
Table 5. Key Players of Other
Table 6. Global Iron Deficiency Anemia Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Iron Deficiency Anemia Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Iron Deficiency Anemia Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Iron Deficiency Anemia Therapy Market Share by Regions (2016-2021)
Table 10. Global Iron Deficiency Anemia Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Iron Deficiency Anemia Therapy Market Share by Regions (2022-2027)
Table 12. Iron Deficiency Anemia Therapy Market Trends
Table 13. Iron Deficiency Anemia Therapy Market Drivers
Table 14. Iron Deficiency Anemia Therapy Market Challenges
Table 15. Iron Deficiency Anemia Therapy Market Restraints
Table 16. Global Iron Deficiency Anemia Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Iron Deficiency Anemia Therapy Market Share by Players (2016-2021)
Table 18. Global Top Iron Deficiency Anemia Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Iron Deficiency Anemia Therapy as of 2020)
Table 19. Ranking of Global Top Iron Deficiency Anemia Therapy Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Iron Deficiency Anemia Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Iron Deficiency Anemia Therapy Product Solution and Service
Table 23. Date of Enter into Iron Deficiency Anemia Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Iron Deficiency Anemia Therapy Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Iron Deficiency Anemia Therapy Revenue Market Share by Type (2016-2021)
Table 27. Global Iron Deficiency Anemia Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Iron Deficiency Anemia Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Iron Deficiency Anemia Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Iron Deficiency Anemia Therapy Revenue Market Share by Application (2016-2021)
Table 31. Global Iron Deficiency Anemia Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Iron Deficiency Anemia Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Iron Deficiency Anemia Therapy Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Iron Deficiency Anemia Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Iron Deficiency Anemia Therapy Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Iron Deficiency Anemia Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Iron Deficiency Anemia Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Iron Deficiency Anemia Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Iron Deficiency Anemia Therapy Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Iron Deficiency Anemia Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Iron Deficiency Anemia Therapy Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Iron Deficiency Anemia Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Iron Deficiency Anemia Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Iron Deficiency Anemia Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Iron Deficiency Anemia Therapy Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Iron Deficiency Anemia Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Iron Deficiency Anemia Therapy Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Iron Deficiency Anemia Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Iron Deficiency Anemia Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Iron Deficiency Anemia Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Iron Deficiency Anemia Therapy Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Iron Deficiency Anemia Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Iron Deficiency Anemia Therapy Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Iron Deficiency Anemia Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Iron Deficiency Anemia Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Iron Deficiency Anemia Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Iron Deficiency Anemia Therapy Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Iron Deficiency Anemia Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Iron Deficiency Anemia Therapy Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Iron Deficiency Anemia Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Iron Deficiency Anemia Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Iron Deficiency Anemia Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 63. Allergan Company Details
Table 64. Allergan Business Overview
Table 65. Allergan Iron Deficiency Anemia Therapy Product
Table 66. Allergan Revenue in Iron Deficiency Anemia Therapy Business (2016-2021) & (US$ Million)
Table 67. Allergan Recent Development
Table 68. AMAG Pharmaceuticals Company Details
Table 69. AMAG Pharmaceuticals Business Overview
Table 70. AMAG Pharmaceuticals Iron Deficiency Anemia Therapy Product
Table 71. AMAG Pharmaceuticals Revenue in Iron Deficiency Anemia Therapy Business (2016-2021) & (US$ Million)
Table 72. AMAG Pharmaceuticals Recent Development
Table 73. Integra Lifesciences Company Details
Table 74. Integra Lifesciences Business Overview
Table 75. Integra Lifesciences Iron Deficiency Anemia Therapy Product
Table 76. Integra Lifesciences Revenue in Iron Deficiency Anemia Therapy Business (2016-2021) & (US$ Million)
Table 77. Integra Lifesciences Recent Development
Table 78. Galderma Pharma Company Details
Table 79. Galderma Pharma Business Overview
Table 80. Galderma Pharma Iron Deficiency Anemia Therapy Product
Table 81. Galderma Pharma Revenue in Iron Deficiency Anemia Therapy Business (2016-2021) & (US$ Million)
Table 82. Galderma Pharma Recent Development
Table 83. Teoxane Company Details
Table 84. Teoxane Business Overview
Table 85. Teoxane Iron Deficiency Anemia Therapy Product
Table 86. Teoxane Revenue in Iron Deficiency Anemia Therapy Business (2016-2021) & (US$ Million)
Table 87. Teoxane Recent Development
Table 88. Sinclair Pharma Company Details
Table 89. Sinclair Pharma Business Overview
Table 90. Sinclair Pharma Iron Deficiency Anemia Therapy Product
Table 91. Sinclair Pharma Revenue in Iron Deficiency Anemia Therapy Business (2016-2021) & (US$ Million)
Table 92. Sinclair Pharma Recent Development
Table 93. Pieris Company Details
Table 94. Pieris Business Overview
Table 95. Pieris Iron Deficiency Anemia Therapy Product
Table 96. Pieris Revenue in Iron Deficiency Anemia Therapy Business (2016-2021) & (US$ Million)
Table 97. Pieris Recent Development
Table 98. Pharmacosmos AS Company Details
Table 99. Pharmacosmos AS Business Overview
Table 100. Pharmacosmos AS Revenue in Iron Deficiency Anemia Therapy Business (2016-2021) & (US$ Million)
Table 101. Pharmacosmos AS Recent Development
Table 102. Johnson & Johnson Company Details
Table 103. Johnson & Johnson Business Overview
Table 104. Johnson & Johnson Iron Deficiency Anemia Therapy Product
Table 105. Johnson & Johnson Revenue in Iron Deficiency Anemia Therapy Business (2016-2021) & (US$ Million)
Table 106. Johnson & Johnson Recent Development
Table 107. Luitpold Pharmaceuticals Company Details
Table 108. Luitpold Pharmaceuticals Business Overview
Table 109. Luitpold Pharmaceuticals Iron Deficiency Anemia Therapy Product
Table 110. Luitpold Pharmaceuticals Revenue in Iron Deficiency Anemia Therapy Business (2016-2021) & (US$ Million)
Table 111. Luitpold Pharmaceuticals Recent Development
Table 112. Keryx Biopharmaceuticals Company Details
Table 113. Keryx Biopharmaceuticals Business Overview
Table 114. Keryx Biopharmaceuticals Iron Deficiency Anemia Therapy Product
Table 115. Keryx Biopharmaceuticals Revenue in Iron Deficiency Anemia Therapy Business (2016-2021) & (US$ Million)
Table 116. Keryx Biopharmaceuticals Recent Development
Table 117. Vifor Pharma Company Details
Table 118. Vifor Pharma Business Overview
Table 119. Vifor Pharma Iron Deficiency Anemia Therapy Product
Table 120. Vifor Pharma Revenue in Iron Deficiency Anemia Therapy Business (2016-2021) & (US$ Million)
Table 121. Vifor Pharma Recent Development
Table 122. Akebia Therapeutics Company Details
Table 123. Akebia Therapeutics Business Overview
Table 124. Akebia Therapeutics Iron Deficiency Anemia Therapy Product
Table 125. Akebia Therapeutics Revenue in Iron Deficiency Anemia Therapy Business (2016-2021) & (US$ Million)
Table 126. Akebia Therapeutics Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Iron Deficiency Anemia Therapy Market Share by Type: 2020 VS 2027
Figure 2. Oral Iron Therapy Features
Figure 3. Parenteral Iron Therapy Features
Figure 4. Red Blood Cell Transfusion Features
Figure 5. Other Features
Figure 6. Global Iron Deficiency Anemia Therapy Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Home Healthcare Case Studies
Figure 10. Other Case Studies
Figure 11. Iron Deficiency Anemia Therapy Report Years Considered
Figure 12. Global Iron Deficiency Anemia Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Iron Deficiency Anemia Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Iron Deficiency Anemia Therapy Market Share by Regions: 2020 VS 2027
Figure 15. Global Iron Deficiency Anemia Therapy Market Share by Regions (2022-2027)
Figure 16. Global Iron Deficiency Anemia Therapy Market Share by Players in 2020
Figure 17. Global Top Iron Deficiency Anemia Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Iron Deficiency Anemia Therapy as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Iron Deficiency Anemia Therapy Revenue in 2020
Figure 19. Global Iron Deficiency Anemia Therapy Revenue Market Share by Type (2016-2021)
Figure 20. Global Iron Deficiency Anemia Therapy Revenue Market Share by Type (2022-2027)
Figure 21. North America Iron Deficiency Anemia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Iron Deficiency Anemia Therapy Market Share by Type (2016-2027)
Figure 23. North America Iron Deficiency Anemia Therapy Market Share by Application (2016-2027)
Figure 24. North America Iron Deficiency Anemia Therapy Market Share by Country (2016-2027)
Figure 25. United States Iron Deficiency Anemia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Iron Deficiency Anemia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Iron Deficiency Anemia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Iron Deficiency Anemia Therapy Market Share by Type (2016-2027)
Figure 29. Europe Iron Deficiency Anemia Therapy Market Share by Application (2016-2027)
Figure 30. Europe Iron Deficiency Anemia Therapy Market Share by Country (2016-2027)
Figure 31. Germany Iron Deficiency Anemia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Iron Deficiency Anemia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Iron Deficiency Anemia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Iron Deficiency Anemia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Iron Deficiency Anemia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Iron Deficiency Anemia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Iron Deficiency Anemia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Iron Deficiency Anemia Therapy Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Iron Deficiency Anemia Therapy Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Iron Deficiency Anemia Therapy Market Share by Region (2016-2027)
Figure 41. China Iron Deficiency Anemia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Iron Deficiency Anemia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Iron Deficiency Anemia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Iron Deficiency Anemia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Iron Deficiency Anemia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Iron Deficiency Anemia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Iron Deficiency Anemia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Iron Deficiency Anemia Therapy Market Share by Type (2016-2027)
Figure 49. Latin America Iron Deficiency Anemia Therapy Market Share by Application (2016-2027)
Figure 50. Latin America Iron Deficiency Anemia Therapy Market Share by Country (2016-2027)
Figure 51. Mexico Iron Deficiency Anemia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Iron Deficiency Anemia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Iron Deficiency Anemia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Iron Deficiency Anemia Therapy Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Iron Deficiency Anemia Therapy Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Iron Deficiency Anemia Therapy Market Share by Country (2016-2027)
Figure 57. Turkey Iron Deficiency Anemia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Iron Deficiency Anemia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Iron Deficiency Anemia Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Allergan Revenue Growth Rate in Iron Deficiency Anemia Therapy Business (2016-2021)
Figure 61. AMAG Pharmaceuticals Revenue Growth Rate in Iron Deficiency Anemia Therapy Business (2016-2021)
Figure 62. Integra Lifesciences Revenue Growth Rate in Iron Deficiency Anemia Therapy Business (2016-2021)
Figure 63. Galderma Pharma Revenue Growth Rate in Iron Deficiency Anemia Therapy Business (2016-2021)
Figure 64. Teoxane Revenue Growth Rate in Iron Deficiency Anemia Therapy Business (2016-2021)
Figure 65. Sinclair Pharma Revenue Growth Rate in Iron Deficiency Anemia Therapy Business (2016-2021)
Figure 66. Pieris Revenue Growth Rate in Iron Deficiency Anemia Therapy Business (2016-2021)
Figure 67. Pharmacosmos AS Revenue Growth Rate in Iron Deficiency Anemia Therapy Business (2016-2021)
Figure 68. Johnson & Johnson Revenue Growth Rate in Iron Deficiency Anemia Therapy Business (2016-2021)
Figure 69. Luitpold Pharmaceuticals Revenue Growth Rate in Iron Deficiency Anemia Therapy Business (2016-2021)
Figure 70. Keryx Biopharmaceuticals Revenue Growth Rate in Iron Deficiency Anemia Therapy Business (2016-2021)
Figure 71. Vifor Pharma Revenue Growth Rate in Iron Deficiency Anemia Therapy Business (2016-2021)
Figure 72. Akebia Therapeutics Revenue Growth Rate in Iron Deficiency Anemia Therapy Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界の鉄欠乏性貧血治療薬市場 2021：企業別、地域別、種類・用途別 The Iron Deficiency Anemia Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…- 世界の貧血治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anemia Drugs Market The global Anemia Drugs market size is projected to reach US$ 15910 million by 2026, from US$ 11620 million in 2019, at a CAGR of 4.5% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a br…
- 世界の貧血治療市場規模・現状・予測（2021年-2027年） Anemia is a disease in which the blood does not carry the optimal amount of oxygen due to red blood cell count or a severe reduction, in our report, it studies iron deficiency anemia, sickle cell anemia, pernicious anemia, hemolytic anemia. The iron deficiency anemia market segment accounted for the…
- 世界の貧血治療市場規模・現状・予測（2021年-2027年） Anemia is a disease in which the blood does not carry the optimal amount of oxygen due to red blood cell count or a severe reduction, in our report, it studies iron deficiency anemia, sickle cell anemia, pernicious anemia, hemolytic anemia. The iron deficiency anemia market segment accounted for the…
- 世界の鎌状赤血球貧血治療薬市場規模・現状・予測（2021年-2027年） Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglo…